AAM
Aureus Asset Management Portfolio holdings
AUM
$1.56B
This Quarter Return
+7.55%
1 Year Return
+22.77%
3 Year Return
+88.43%
5 Year Return
+131.92%
10 Year Return
+447.31%
AUM
$576M
AUM Growth
+$576M
(+13%)
Cap. Flow
+$20.9M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
29.47%
Holding
197
New
36
Increased
78
Reduced
42
Closed
15
Top Buys
| 1 |
Charles Schwab
SCHW
|
$12.7M |
| 2 |
Sherwin-Williams
SHW
|
$11.6M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$2.64M |
| 4 |
Zoetis
ZTS
|
$1.94M |
| 5 |
GRA
W.R. Grace & Co.
GRA
|
$1.86M |
Top Sells
| 1 |
Newell Brands
NWL
|
$10.8M |
| 2 |
Stanley Black & Decker
SWK
|
$6.75M |
| 3 |
American International
AIG
|
$6.71M |
| 4 |
Booz Allen Hamilton
BAH
|
$4.17M |
| 5 |
Schlumberger
SLB
|
$3.76M |
Sector Composition
| 1 | Healthcare | 17.94% |
| 2 | Financials | 15.18% |
| 3 | Technology | 12.18% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PayPal
PYPL
$67.1B
| $11.2M | 1.95% |
226,229
-3,170
| -1% | -$158K |
|
|
GRA
27
DELISTED
W.R. Grace & Co.
GRA
| $11.2M | 1.95% |
160,715
+26,631
| +20% | +$1.86M |
|
|
28
Booz Allen Hamilton
BAH
$13.4B
| $11.2M | 1.95% |
313,194
-116,571
| -27% | -$4.17M |
|
29
Bristol-Myers Squibb
BMY
$96B
| $10.4M | 1.8% |
187,906
+23,663
| +14% | +$1.3M |
|
|
30
Schlumberger
SLB
$55B
| $9.51M | 1.65% |
132,480
-52,335
| -28% | -$3.76M |
|
31
Enviri
NVRI
$911M
| $8.77M | 1.52% |
577,130
+11,920
| +2% | +$181K |
|
32
HealthEquity
HQY
$7.72B
| $8.31M | 1.44% |
180,303
+8,440
| +5% | +$389K |
|
33
Phillips 66
PSX
$54B
| $7.41M | 1.29% |
93,238
-2,590
| -3% | -$206K |
|
34
Cabot Corp
CBT
$4.34B
| $6.91M | 1.2% |
132,724
+900
| +0.7% | +$46.8K |
|
35
Exxon Mobil
XOM
$487B
| $6.88M | 1.19% |
83,237
+5,069
| +6% | +$419K |
|
|
36
American International
AIG
$45.1B
| $6.74M | 1.17% |
109,084
-108,552
| -50% | -$6.71M |
|
|
NBL
37
DELISTED
Noble Energy, Inc.
NBL
| $6.38M | 1.11% |
203,703
-72,074
| -26% | -$2.26M |
|
38
Starbucks
SBUX
$100B
| $5.38M | 0.93% |
89,201
+21,341
| +31% | +$1.29M |
|
39
Microsoft
MSFT
$3.77T
| $4.07M | 0.71% |
59,501
+5,873
| +11% | +$402K |
|
40
Danaher
DHR
$147B
| $3.66M | 0.64% |
44,204
+5,802
| +15% | +$480K |
|
41
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.65M | 0.63% |
15,231
-10,890
| -42% | -$2.61M |
|
42
Amgen
AMGN
$155B
| $3.01M | 0.52% |
18,799
-756
| -4% | -$121K |
|
|
43
Ultragenyx Pharmaceutical
RARE
$2.89B
| $2.93M | 0.51% |
50,740
+45,840
| +936% | +$2.64M |
|
44
Johnson & Johnson
JNJ
$427B
| $2.87M | 0.5% |
23,285
-589
| -2% | -$72.6K |
|
45
Vanguard Growth ETF
VUG
$185B
| $2.54M | 0.44% |
20,175
| – | – |
|
|
CCMP
46
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.24M | 0.39% |
28,890
| – | – |
|
47
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $2.12M | 0.37% |
52,008
+10,236
| +25% | +$418K |
|
48
JPMorgan Chase
JPM
$829B
| $2.08M | 0.36% |
23,908
+2,344
| +11% | +$204K |
|
49
3M
MMM
$82.8B
| $2.08M | 0.36% |
10,589
+2,446
| +30% | +$481K |
|
50
iShares Core S&P 500 ETF
IVV
$662B
| $1.94M | 0.34% |
8,035
-4,075
| -34% | -$982K |
|